Contracts › 75F40124C00106
75F40124C00106: Baa for Development of Drug Development Tools for Adtkd
Awarded to The Critical Path Institute by Food and Drug Administration (FDA).
$2.8Mobligated
$3.4Mpotential value
21 August 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40124C00106 |
|---|---|
| Awardee | The Critical Path Institute |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | AZ |
| Offers received | 1 |
| Period of performance | 16 August 2024 to 21 August 2027 |
| Potential end | 21 August 2028 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record